Madrigal Pharmaceuticals, Inc. MDGL Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$94.39M-28.9% | -$58.58M+1.4% | -$114.19M-6.8% | -$42.28M+72.2% | -$73.24M+50.4% | ||
| $386K+1.8% | $392K+8.0% | $358K+20.1% | $377K+41.2% | $379K+126% | ||
| $34.02M+62.5% | $25.79M+45.9% | $26.25M+46.7% | $25.16M+3.1% | $20.93M+5.2% | ||
| -$167.44M-88.4% | -$133.46M-27.7% | —— | -$47.05M+65.1% | -$88.89M+40.4% | ||
| $3.85M— | —— | $857K+10.0% | $0-100% | $0-100% | ||
| $192.19M+17.3% | $27.58M+158% | —— | $47.86M+139% | $163.88M+67.1% | ||
| $2.33M-73.0% | $8.96M-54.7% | $236.65M+3,071% | $1.74M-98.7% | $8.64M-98.5% | ||
| $28.41M-66.0% | —— | $109.5M— | $2.55M— | $83.63M-84.0% | ||
| -$171.28M-92.7% | -$133.07M-27.1% | —— | -$47.05M+65.2% | -$88.89M+40.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Madrigal Pharmaceuticals, Inc. generate?
- Madrigal Pharmaceuticals, Inc. (MDGL) generated -$436.8M in operating cash flow over the trailing twelve months.
- What is Madrigal Pharmaceuticals, Inc.'s free cash flow?
- After $4.7M of capital expenditures, Madrigal Pharmaceuticals, Inc.'s free cash flow was -$440.3M over the trailing twelve months, up 3.7% year over year.
- Where does Madrigal Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Madrigal Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
